美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
65219-564-20	65219-564	HUMAN PRESCRIPTION DRUG	MITOMYCIN	MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230115	N/A	ANDA	ANDA215687	Fresenius Kabi USA, LLC	MITOMYCIN	5 mg/10mL	1 VIAL in 1 CARTON (65219-564-20) / 10 mL in 1 VIAL
65219-566-20	65219-566	HUMAN PRESCRIPTION DRUG	MITOMYCIN	MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230115	N/A	ANDA	ANDA215687	Fresenius Kabi USA, LLC	MITOMYCIN	20 mg/40mL	1 VIAL in 1 CARTON (65219-566-20) / 40 mL in 1 VIAL
68083-483-01	68083-483	HUMAN PRESCRIPTION DRUG	MITOMYCIN	MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211020	N/A	ANDA	ANDA215687	Gland Pharma Limited	MITOMYCIN	5 mg/10mL	1 VIAL in 1 CARTON (68083-483-01) / 10 mL in 1 VIAL
68083-484-01	68083-484	HUMAN PRESCRIPTION DRUG	MITOMYCIN	MITOMYCIN	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20211020	N/A	ANDA	ANDA215687	Gland Pharma Limited	MITOMYCIN	20 mg/40mL	1 VIAL in 1 CARTON (68083-484-01) / 40 mL in 1 VIAL
25021-250-20	25021-250	HUMAN PRESCRIPTION DRUG	Mitomycin	Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230615	N/A	ANDA	ANDA215687	Sagent Pharmaceuticals	MITOMYCIN	5 mg/10mL	1 VIAL in 1 CARTON (25021-250-20) / 10 mL in 1 VIAL
25021-251-50	25021-251	HUMAN PRESCRIPTION DRUG	Mitomycin	Mitomycin	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20230615	N/A	ANDA	ANDA215687	Sagent Pharmaceuticals	MITOMYCIN	20 mg/40mL	1 VIAL in 1 CARTON (25021-251-50) / 40 mL in 1 VIAL